Hiperosmolar Hiperglisemik Durumlu Hastaya Yaklaşım
Özet
Hiperosmolar Hiperglisemik Durum (HHD), ciddi hiperglisemi ve keton negatifliği ile seyreden diyabetin akut ve ölümcül bir komplikasyonudur. Genellikle 50 yaş üzeri ve 65 yaş üstü tip 2 diyabetli bireylerde enfeksiyon, akut koroner sendrom gibi tetikleyici faktörlerle ortaya çıkar. Kan glukozunun >600 mg/dl ve plazma ozmolaritesinin ≥320 mOsm/kg olması ile tanı konur. Klinik tabloda belirgin sıvı ve elektrolit kaybı (7-11 litre), dehidratasyon bulguları ve komaya kadar varabilen nörolojik anormallikler görülür. Tedavinin temelini izotonik sıvı replasmanı, elektrolit (özellikle potasyum) dengesinin sağlanması ve i.v. regüler insülin infüzyonu (0,10 IU/kg/saat) oluşturur. Kan glukoz düzeyi 250-300 mg/dl seviyesine gerilediğinde, serebral ödem riskini önlemek amacıyla insülin dozu azaltılarak sıvıya dekstroz eklenmelidir. Ayrıca tromboembolik komplikasyonları önlemek için heparin tedavisi ve yakından nörolojik ve renal takip önerilir.
Referanslar
Kitabchi AE, Umpierrez GE, Murphy MB, Barrett EJ, Kreisberg RA, Malone JI, et al. Management of hyperglycemic crises in patients with diabetes. Vol. 24, Diabetes Care. American Diabetes Association Inc. 2001 p. 131–53. Available from: https://pubmed.ncbi.nlm.nih.gov/11194218/
Centers for Disease Control and Prevention, Diabetes Public Health Resource [cited 2021 Feb 10]. Available from: https://www.cdc.gov/diabetes/statistics/hospitalization_national.html
DeFronzo RA, Matsuda M. Diabetic ketoacidosis. A combined metabolic-nephrologic approach to therapy. Diabetes Reviews. 1994;2(2):209–38. Available from: https://scholars.uthscsa.edu/en/publications/diabetic-ketoacidosis-a-combined-metabolic-nephrologic-approach-t
Adrogué HJ, Lederer ED, Suki WN, Eknoyan G. Determinants of plasma potassium levels in diabetic ketoacidosis. Medicine (United States). 1986;65(3):163–72. Available from: https://pubmed.ncbi.nlm.nih.gov/3084904/
Khardori R, Soler NG. Hyperosmolar hyperglycemic nonketotic syndrome. Report of 22 cases and brief review. Vol. 77, The American Journal of Medicine. Am J Med; 1984. p. 899–904. Available from: https://pubmed.ncbi.nlm.nih.gov/6496545/
Kaminska ES, Pourmotabbed G. Spurious laboratory values in diabetic ketoacidosis and hyperlipidemia. American Journal of Emergency Medicine. 1993;11(1):77–80. Available from: https://pubmed.ncbi.nlm.nih.gov/8447878/
Rumbak MJ, Hughes TA, Kitabchi AE. Pseudonormoglycemia in diabetic ketoacidosis with elevated triglycerides. American Journal of Emergency Medicine. 1991;9(1):61–3. Available from: https://pubmed.ncbi.nlm.nih.gov/1898702/
Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. In: Diabetes Care [Internet]. Diabetes Care; 2009. p. 1335–43. Available from: https://pubmed.ncbi.nlm.nih.gov/19564476/
Arieff AI, Carroll HJ. Nonketotic hyperosmolar coma with hyperglycemia: Clinical features, pathophysiology, renal function, acid-base balance, plasma-cerebrospinal fluid equilibria and the effects of theraphy in 37 cases1. Medicine (United States). 1972;51(2):73–94. Available from: https://pubmed.ncbi.nlm.nih.gov/5013637/
Fulop M, Tannenbaum H, Dreyer N. KETOTIC HYPEROSMOLAR COMA. The Lancet . 1973;302(7830):635–9. Available from: https://pubmed.ncbi.nlm.nih.gov/4125618/
Barrett EJ, DeFronzo RA. Diabetic ketoacidosis: Diagnosis and treatment. Hospital Practice. 1984;19(4):89–104. Available from: https://pubmed.ncbi.nlm.nih.gov/6425326/
Bratusch-Marrain P. The effect of hyperosmolarity on glucose metabolism. Pract Cardiol. 1985;11.
Nyenwe EA, Kitabchi AE. Evidence-based management of hyperglycemic emergencies in diabetes mellitus. Vol. 94, Diabetes Research and Clinical Practice. Diabetes Res Clin Pract; 2011. p. 340–51. Available from: https://pubmed.ncbi.nlm.nih.gov/21978840/
Savage MW, Dhatariya KK, Kilvert A, Rayman G, Rees JAE, Courtney CH, et al. Joint British Diabetes Societies guideline for the management of diabetic ketoacidosis. Diabetic Medicine. 2011;28(5):508–15. Available from: https://pubmed.ncbi.nlm.nih.gov/21255074/
Brown PM, Tompkins C V., Juul S, Sönksen PH. Mechanism of action of insulin in diabetic patients: A dose-related effect on glucose production and utilisation. British Medical Journal [Internet]. 1978;1(6122):1239–42. Available from: https://pubmed.ncbi.nlm.nih.gov/647213/